FGK Clinical Research has offices in various countries.
For clinical studies (Phase I, II, III, IV) , FGK offers full-service support for the following study countries:
Western and Eastern Europe:
Study countries monitored by our own local, permanently employed native speaking CRAs, ensuring stable and dedicated support throughout the project:
- GERMANY
- AUSTRIA
- SWITZERLAND
- UNITED KINGDOM
- POLAND
- HUNGARY
- CZECH REPUBLIC
- SLOVAKIA
- THE NETHERLANDS
- BELGIUM
Study countries monitored by preferred providers:
- SCANDINAVIA, ITALY, FRANCE, SPAIN, PORTUGAL, ROMANIA, GREECE
USA:
For small projects in the US with only few sites we engage via our subsidiary with experienced US-freelance CRAs who are likely to remain with us for the full duration of the project.
This approach aligns with local norms and reduces local administrative costs and the risk for team member turnover for US clinical studies.
For larger projects we have qualified local partners with whom we work on a mutual basis.
ROW:
Study countries monitored by preferred providers:
- ISRAEL, AUSTRALIA, CANADA
Accelerated Patient Recruitment & Retention
In decades of clinical study conduct, we have been convinced that credible CROs position resources where patient populations exist and where standards of care facilitate access.
CRO staff must be linguistically proficient and fully acquainted with culture and standards of care within each assigned country.
That distinction matters more than most sponsors realize. A global footprint listed on a website differs considerably from genuine in-country execution capability.
Our regional specialists maintain direct, established relationships with local national competent authorities and site networks, forming relationships built over years, not assembled for a proposal.
Seamless Multi-Country Operations:
We are very flexible with regards to country selection as we have great long-term collaboration partners in the majority of European countries as well as Israel, the US, Canada and Australia to ensure the most promising study countries for each indication, IMP and/or Device can be realized.
Our established network of likeminded CROs allows to add highly experienced local professionals, who are integrated into our project team like internal staff and for whom we take on full responsibility.
FGK clinical research – YOUR EUROPEAN FULL SERVICE CRO
Flexible. Efficient. Owner-Driven.
Whether you are launching a pivotal Phase III international trial or seeking targeted regional patient cohorts, we deliver your milestones on time and within budget.